Congratulations to Dr. Carl A. Laskin, TRIO’s Managing Director and Founding Partner, on receiving the CFAS Award of Excellence for 2022. In granting this award, the CFAS Award of Excellence committee and the Board of Directors honours Dr. Laskin for his outstanding contribution to and leadership in the field of Reproductive Medicine and Science.
The Canadian Fertility and Andrology Society is Canada’s national organization of professionals dealing with reproductive medicine. Its mission is to responsibly advance reproductive science and medicine in Canada through leadership, research, and guidance.
“I would like to thank my peers at the CFAS for recognizing my work by granting me this prestigious award,” said Dr. Laskin. “I consider it a privilege and a badge of honour, and I look forward to continuing to support and contribute to the CFAS as well as the practice of Reproductive Medicine.”
Dr. Carl A. Laskin is an internationally recognized expert in the specialized field of reproductive immunology and autoimmune diseases in pregnancy. As a widely respected specialist both nationally and internationally, Dr. Laskin is well known for his clinical and research activities in the field of recurrent pregnancy loss, as well as pregnancy in women with autoimmune diseases such as systemic lupus. In addition to his practice at TRIO, Dr. Laskin is an Associate Professor in the departments of Medicine (Rheumatology) and Obstetrics and Gynaecology (REI) at the University of Toronto; an Executive member of the Obstetric Medicine Program, University of Toronto; and a Past President of the Canadian Fertility and Andrology Society (CFAS).
